Health outcomes with and without use of inotropic therapy in cardiac surgery: Results of a propensity score-matched analysis

Anesthesiology

Volumn 120, Issue 5, 2014, Pages 1098-1108

  Nielsen, Dorthe Viemose ^a   Hansen, Malene Kærslund ^a   Johnsen, Søren Paaske ^a   Hansen, Mads ^b   Hindsholm, Karsten ^c   Jakobsen, Carl Johan ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; LEVOSIMENDAN; MILRINONE;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DENMARK; DISEASE ASSOCIATION; DRUG USE; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART INFARCTION; HEART SURGERY; HEART VALVE SURGERY; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PEROPERATIVE CARE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPENSITY SCORE; RENAL REPLACEMENT THERAPY; SURGICAL MORTALITY; THORACIC AORTA SURGERY; UNIVERSITY HOSPITAL;

AGED; CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; COHORT STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROPENSITY SCORE; PROSPECTIVE STUDIES; REGISTRIES; TREATMENT OUTCOME;

EID: 84899484494     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000224     Document Type: Article

References (34)

1. Ahmed I, House CM, Nelson WB: Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB). J Cardiothorac Surg 2009; 4:24
2. Gillies M, Bellomo R, Doolan L, Buxton B: Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery-A systematic literature review. Crit Care 2005; 9:266-79 (Pubitemid 40796804)
3. Fellahi JL, Parienti JJ, Hanouz JL, Plaud B, Riou B, Ouattara A: Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: Propensity-adjusted analyses. Anesthesiolog y 2008; 108:979-87
4. Fleming GA, Murray KT, Yu C, Byrne JG, Greelish JP, Petracek MR, Hoff SJ, Ball SK, Brown NJ, Pretorius M: Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery. Circulation 2008; 118:1619-25
5. Shahin J, DeVarennes B, Tse CW, Amarica DA, Dial S: The relationship between inotrope exposure, six-hour postoperative physiological variables, hospital mortality and renal dysfunction in patients undergoing cardiac surgery. Crit Care 2011; 15:R162
6. Butterworth J: Dobutamine: Too dangerous for "routine" administration? Anesthesiolog y 2008; 108:973-4
7. Nielsen DV, Johnsen SP, Madsen M, Jakobsen CJ: Variation in use of peroperative inotropic support therapy in cardiac surgery: Time for reflection? Acta Anaesthesiol Scand 2011; 55:352-8
8. Hernandez AF, Li S, Dokholyan RS, O'Brien SM, Ferguson TB, Peterson ED: Variation in perioperative vasoactive therapy in cardiovascular surgical care: Data from the Society of Thoracic Surgeons. Am Heart J 2009; 158:47-52
9. Kastrup M, Markewitz A, Spies C, Carl M, Erb J, Grosse J, Schirmer U: Current practice of hemodynamic monitoring and vasopressor and inotropic therapy in post-operative cardiac surgery patients in Germany: Results from a postal survey. Acta Anaesthesiol Scand 2007; 51:347-58
10. Butterworth JF IV, Legault C, Royster RL, Hammon JW Jr: Factors that predict the use of positive inotropic drug support after cardiac valve surgery. Anesth Analg 1998; 86:461-7 (Pubitemid 28119400)
11. Abildstrøm SZ, Madsen M: The Danish Heart Register. Scand J Public Health 2011; 39:46-9
12. Schmidt M, Maeng M, Jakobsen CJ, Madsen M, Thuesen L, Nielsen PH, Bøtker HE, Sørensen HT: Existing data sources for clinical epidemiology: The Western Denmark Heart Registry. Clin Epidemiol 2010; 2:137-44
13. Pedersen CB, Gøtzsche H, Møller JO, Mortensen PB: The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006; 53:441-9 (Pubitemid 44816920)
14. Rubin DB: The design versus the analysis of observational studies for causal effects: Parallels with the design of randomized trials. Stat Med 2007; 26:20-36 (Pubitemid 46099415)
15. Rubin DB: Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997; 127(8 Pt 2):757-63 (Pubitemid 27446562)
16. Austin PC: An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 2011; 46:399-24
17. Austin PC: Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: A systematic review and suggestions for improvement. J Thorac Cardiovasc Surg 2007; 134:1128-35
18. Austin PC, Grootendorst P, Anderson GM: A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: A Monte Carlo study. Stat Med 2007; 26:734-53 (Pubitemid 46206593)
19. Hedberg M, Boivie P, Engström KG: Early and delayed stroke after coronary surgery-An analysis of risk factors and the impact on short-and long-term survival. Eur J Cardiothorac Surg 2011; 40:379-87
20. Attaran S, Shaw M, Bond L, Pullan MD, Fabri BM: Atrial fibrillation postcardiac surgery: A common but a morbid complication. Interact Cardiovasc Thorac Surg 2011; 12:772-7
21. Heringlake M, Knappe M, Vargas Hein O, Lufft H, Kindgen-Milles D, Böttiger BW, Weigand MR, Klaus S, Schirmer U: Renal dysfunction according to the ADQI-RIFLE system and clinical practice patterns after cardiac surgery in Germany. Minerva Anestesiol 2006; 72:645-54 (Pubitemid 44251570)
22. Parissis JT, Rafouli-Stergiou P, Stasinos V, Psarogiannakopoulos P, Mebazaa A: Inotropes in cardiac patients: Update 2011. Curr Opin Crit Care 2010; 16:432-41
23. Maharaj R, Metaxa V: Levosimendan and mortality after coronary revascularisation: A meta-analysis of randomised controlled trials. Crit Care 2011; 15:R140
24. Thackray S, Easthaugh J, Freemantle N, Cleland JG: The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-A meta-regression analysis. Eur J Heart Fail 2002; 4:515-29 (Pubitemid 36564973)
25. Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M: Short-term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized controlled trial. JAMA 2002; 287:1541-7 (Pubitemid 34269999)
26. Amsallem E, Kasparian C, Haddour G, Boissel J, Nony P: Phosphodiesterase III inhibitors for heart failure. Cochrane Database Syst Rev 2005: CD002230
27. Mebazaa A, Parissis J, Porcher R, Gayat E, Nikolaou M, Boas FV, Delgado JF, Follath F: Short-term survival by treatment among patients hospitalized with acute heart failure: The global ALARM-HF registry using propensity scoring methods. Intensive Care Med 2011; 37:290-301
28. Burger AJ, Horton DP, LeJemtel T, Ghali JK, Torre G, Dennish G, Koren M, Dinerman J, Silver M, Cheng ML, Elkayam U: Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT study. Am Heart J 2002; 144:1102-8 (Pubitemid 36026926)
29. Benza RL, Tallaj JA, Felker GM, Zabel KM, Kao W, Bourge RC, Pearce D, Leimburger JD, Borzak S, O'Conner CM, Gheorghiade M: The impact of arrhythmias in acute heart failure. J Card Fail 2004; 10:279-84 (Pubitemid 39092677)
30. Indolfi C, Piscione F, Perrone-Filardi P, Prastaro M, Di Lorenzo E, Saccà L, Salvatore M, Condorelli M, Chiariello M: Inotropic stimulation by dobutamine increases left ventricular regional function at the expense of metabolism in hibernating myocardium. Am Heart J 1996; 132:542-9 (Pubitemid 26347757)
31. Schulz R, Rose J, Martin C, Brodde OE, Heusch G: Development of short-term myocardial hibernation. Its limitation by the severity of ischemia and inotropic stimulation. Circulation 1993; 88:684-95 (Pubitemid 23228069)
32. Lindenfeld J, Albert NM, Boehmer JP, Collins SP, Ezekowitz JA, Givertz MM, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WHW, Teerlink JR, Walsh MN: HFSA 2010 comprehensive heart failure practice guideline. J Card Fail 2010; 16:e1-194
33. Mebazaa A, Pitsis AA, Rudiger A, Toller W, Longrois D, Ricksten SE , Bobek I, De Hert S, Wieselthaler G, Schirmer U, von Segesser LK, Sander M, Poldermans D, Ranucci M, Karpati PC, Wouters P, Seeberger M, Schmid ER, Weder W, Follath F: Clinical review: Practical recommendations on the management of perioperative heart failure in cardiac surgery. Crit Care 2010; 14:201
34. Fellahi JL, Fischer MO, Daccache G, Gerard JL, Hanouz JL: Positive inotropic agents in myocardial ischemia-reperfusion injury: A benefit/risk analysis. Anesthesiolog y 2013; 118:1460-5